Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$214M |
| 2 |
Verizon
VZ
|
+$148M |
| 3 |
Otis Worldwide
OTIS
|
+$142M |
| 4 |
Baidu
BIDU
|
+$124M |
| 5 |
Alibaba
BABA
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$324M |
| 2 |
Amazon
AMZN
|
+$313M |
| 3 |
Bank of America
BAC
|
+$264M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.39% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.76% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
SunCoke Energy
SXC
$794M
| $14.8M | 0.01% |
5,011,181
-627,773
| -11% | -$2M |
|
|
ZGNX
2027
DELISTED
Zogenix, Inc.
ZGNX
| $14.8M | 0.01% |
548,815
-79,986
| -13% | -$2.21M |
|
2028
SAP
SAP
$215B
| $14.8M | 0.01% |
105,837
-1,993
| -2% | -$246K |
|
2029
Karyopharm Therapeutics
KPTI
$155M
| $14.8M | 0.01% |
52,057
-20,550
| -28% | -$6.08M |
|
2030
STMicroelectronics
STM
$43.1B
| $14.8M | 0.01% |
539,311
-895
| -0.2% | -$22.2K |
|
2031
Movado Group
MOV
$840M
| $14.8M | 0.01% |
1,361,677
-16,610
| -1% | -$179K |
|
|
NEWR
2032
DELISTED
New Relic, Inc.
NEWR
| $14.7M | 0.01% |
213,283
-2,661
| -1% | -$159K |
|
2033
Upland Software
UPLD
$13.3M
| $14.7M | 0.01% |
42,249
+2,057
| +5% | +$641K |
|
2034
American Coastal Insurance
ACIC
$536M
| $14.7M | 0.01% |
1,877,050
-29,197
| -2% | -$237K |
|
|
CHUY
2035
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $14.7M | 0.01% |
985,600
+3,249
| +0.3% | +$48.6K |
|
|
PTVCB
2036
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $14.6M | 0.01% |
972,048
-12,218
| -1% | -$171K |
|
2037
Spok Holdings
SPOK
$229M
| $14.6M | 0.01% |
1,565,446
-25,191
| -2% | -$261K |
|
|
TCO
2038
DELISTED
Taubman Centers Inc.
TCO
| $14.6M | 0.01% |
387,289
| – | – |
|
2039
AdvanSix
ASIX
$542M
| $14.5M | 0.01% |
1,238,454
-4,362
| -0.4% | -$50.8K |
|
2040
Atlanta Braves Holdings Series B
BATRK
$3.28B
| $14.5M | 0.01% |
736,332
+84,073
| +13% | +$1.67M |
|
2041
Peabody Energy
BTU
$2.54B
| $14.5M | 0.01% |
5,043,541
-254,653
| -5% | -$841K |
|
|
DHIL
2042
DELISTED
Diamond Hill
DHIL
| $14.5M | 0.01% |
127,192
-1,173
| -0.9% | -$123K |
|
2043
Superior Group of Companies
SGC
$199M
| $14.4M | 0.01% |
1,077,233
-3,252
| -0.3% | -$30.8K |
|
2044
Macerich
MAC
$7.4B
| $14.4M | 0.01% |
1,600,365
-242,383
| -13% | -$1.88M |
|
|
EXTN
2045
DELISTED
Exterran Corporation
EXTN
| $14.3M | 0.01% |
2,661,589
-169,014
| -6% | -$958K |
|
|
HOME
2046
DELISTED
At Home Group Inc.
HOME
| $14.2M | 0.01% |
2,183,838
-781,795
| -26% | -$3.2M |
|
|
LFC
2047
DELISTED
China Life Insurance Company Ltd.
LFC
| $14.2M | 0.01% |
1,403,858
-6,900
| -0.5% | -$69.4K |
|
2048
Magnite
MGNI
$2.83B
| $14.2M | 0.01% |
2,121,776
+153,234
| +8% | +$957K |
|
2049
Oil-Dri
ODC
$1.43B
| $14.1M | 0.01% |
815,370
+2,062
| +0.3% | +$35.7K |
|
|
EGRX
2050
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $14.1M | 0.01% |
294,740
-1,379
| -0.5% | -$68.8K |
|
Similar funds
Dimensional Fund Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Dimensional Fund Advisors held 3,428 positions worth $228B, up 19% from $192B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 4.2%. Dimensional Fund Advisors opened 54 new positions and exited 89, leaving the 3,428-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2020 buy was Otis Worldwide: 2,746,401 shares worth $156M.
- Dimensional Fund Advisors added most to AbbVie in Q2 2020, an estimated $214M increase.
- Dimensional Fund Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $324M.
- Dimensional Fund Advisors fully exited Allergan plc in Q2 2020, selling an estimated $259M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $228B portfolio in Q2 2020.
- Dimensional Fund Advisors opened 54 new positions and closed 89 in Q2 2020.
- Dimensional Fund Advisors's portfolio value rose 19% quarter-over-quarter to $228B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.